Pressure BioSciences Inc PBIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PBIO is a good fit for your portfolio.
News
-
Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray
-
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
-
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.80
- Bid/Ask
- $0.12 / $0.14
- Market Cap
- $381,815.60
- Volume/Avg
- 300 / 41,997
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 17
Valuation
Metric
|
PBIO
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.13 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
PBIO
|
---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.02 |
Interest Coverage | −0.88 |
Quick Ratio
PBIO
Profitability
Metric
|
PBIO
|
---|---|
Return on Assets (Normalized) | −1,314.04% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
PBIO
Medical Devices Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Abbott Laboratories
ABT
| Fzcrptqlx | Kjvfzfc | $183.1 Bil | |||
Stryker Corp
SYK
| Fmxnlbtzh | Xytn | $126.3 Bil | |||
Boston Scientific Corp
BSX
| Sfqjmgtjh | Gsyhjz | $110.1 Bil | |||
Medtronic PLC
MDT
| Trxvwzg | Xdvqrm | $100.9 Bil | |||
Edwards Lifesciences Corp
EW
| Rvjvtlfsmt | Cwghprz | $37.6 Bil | |||
DexCom Inc
DXCM
| Bsdyxdcqz | Jttgg | $25.6 Bil | |||
Koninklijke Philips NV ADR
PHG
| Wxjlzydk | Fmsgtg | $24.1 Bil | |||
Steris PLC
STE
| Vxlybtv | Dqcrfp | $23.0 Bil | |||
Zimmer Biomet Holdings Inc
ZBH
| Rcqzqtdqf | Zmcl | $22.9 Bil | |||
Align Technology Inc
ALGN
| Yvydgjy | Ysylx | $16.6 Bil |